IRIS
Biasini, Emiliano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.831
AS - Asia 1.570
EU - Europa 1.286
SA - Sud America 256
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 2
Totale 7.973
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.780
SG - Singapore 901
CN - Cina 347
IT - Italia 338
RU - Federazione Russa 301
BR - Brasile 206
FI - Finlandia 134
VN - Vietnam 121
DE - Germania 114
SE - Svezia 103
GB - Regno Unito 102
LV - Lettonia 70
JO - Giordania 47
NL - Olanda 37
CA - Canada 30
ID - Indonesia 26
AR - Argentina 23
BG - Bulgaria 20
TR - Turchia 20
IN - India 18
MX - Messico 16
HK - Hong Kong 15
JP - Giappone 15
BD - Bangladesh 11
IQ - Iraq 10
UA - Ucraina 10
ZA - Sudafrica 10
PL - Polonia 8
ES - Italia 7
LT - Lituania 7
PY - Paraguay 7
VE - Venezuela 7
AT - Austria 6
FR - Francia 6
KR - Corea 6
AZ - Azerbaigian 5
EC - Ecuador 5
MA - Marocco 5
AE - Emirati Arabi Uniti 4
CO - Colombia 4
EU - Europa 4
IE - Irlanda 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
BE - Belgio 3
BY - Bielorussia 3
CZ - Repubblica Ceca 3
GR - Grecia 3
PH - Filippine 3
PK - Pakistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
KE - Kenya 2
LB - Libano 2
LU - Lussemburgo 2
MY - Malesia 2
AL - Albania 1
AM - Armenia 1
CI - Costa d'Avorio 1
CL - Cile 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
GA - Gabon 1
GD - Grenada 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
NG - Nigeria 1
NP - Nepal 1
QA - Qatar 1
RO - Romania 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 7.973
Salva come PNG Salva come JPEG
Città #
Fairfield 562
Ashburn 549
Singapore 539
Chandler 501
Woodbridge 238
Seattle 232
San Mateo 222
Houston 211
Cambridge 188
Ann Arbor 178
Wilmington 177
Santa Clara 153
Moscow 152
Dallas 138
Columbus 123
Princeton 113
Beijing 87
Helsinki 77
Riga 70
Jacksonville 69
Los Angeles 68
The Dalles 66
New York 62
Trento 54
Munich 51
San Diego 38
Dearborn 34
Buffalo 32
Como 26
Chicago 24
Ho Chi Minh City 24
North Bergen 24
London 23
Boardman 22
San Paolo di Civitate 22
Fremont 19
Hanoi 19
Hefei 19
Orem 19
Sofia 19
São Paulo 17
Denver 16
Jakarta 16
Council Bluffs 15
Hong Kong 15
Dong Ket 14
Rome 14
Salt Lake City 14
Cavalese 13
Izmir 13
Perugia 13
Turku 13
Bologna 12
Norwalk 12
Toronto 12
Falkenstein 11
Stockholm 11
Montreal 10
Shanghai 10
Tokyo 10
Tolentino 10
Elk Grove Village 9
Nanjing 9
Poplar 9
Washington 9
Brooklyn 8
Ninh Bình 8
Nuremberg 8
Amsterdam 7
Bassano del Grappa 7
Curitiba 7
Des Moines 7
Guangzhou 7
Lappeenranta 7
Mexico City 7
Milan 7
Rio de Janeiro 7
San Francisco 7
Vienna 6
Warsaw 6
Amman 5
Atlanta 5
Augusta 5
Baghdad 5
Baku 5
Boston 5
Chennai 5
Costa Mesa 5
Johannesburg 5
Juneau 5
Naples 5
Redondo Beach 5
Altamura 4
Ankara 4
Biên Hòa 4
Bonndorf 4
Bremen 4
Campinas 4
Can Tho 4
Dublin 4
Totale 5.749
Salva come PNG Salva come JPEG
Nome #
Interfering with HuR-RNA Interaction: Design, Synthesis and Biological Characterization of Tanshinone Mimics as Novel, Effective HuR Inhibitors 261
Regulation of HuR structure and function by dihydrotanshinone-I 219
An antipsychotic drug exerts anti-prion effects by altering the localization of the cellular prion protein 211
Full atomistic model of prion structure and conversion 204
Pharmacological inactivation of the prion protein by targeting a folding intermediate 200
A cationic tetrapyrrole inhibits toxic activities of the cellular prion protein 181
A Small-Molecule Inhibitor of Prion Replication and Mutant Prion Protein Toxicity 174
An N-terminal fragment of the prion protein binds to amyloid-β oligomers and inhibits their neurotoxicity in vivo 170
Activation of zebrafish Src family kinases by the prion protein is an amyloid-β-sensitive signal that prevents the endocytosis and degradation of E-cadherin/β-catenin complexes in vivo 165
The prion protein family member Shadoo induces spontaneous ionic currents in cultured cells 157
Understanding prion structure and conversion 157
Acute Neurotoxicity Models of Prion Disease 154
Exploring the role of MKK7 in excitotoxicity and cerebral ischemia: A novel pharmacological strategy against brain injury 149
All-Atom Simulation of HET-s Prion Replication 147
Identification of compounds inhibiting prion replication and toxicity by removing PrPC from the cell surface 145
Mutant prion protein expression is associated with an alteration of the rab GDP dissociation inhibitor α (GDI)/rab11 pathway 140
A novel, drug-based, cellular assay for the activity of neurotoxic mutants of the prion protein 138
A Drug-Based Cellular Assay (DBCA) for studying cytotoxic and cytoprotective activities of the prion protein: A practical guide 138
Characterization of Physical, Mechanical, and Biological Properties of SilkBridge Nerve Conduit after Enzymatic Hydrolysis 138
Pharmacological Agents Targeting the Cellular Prion Protein 136
Common therapeutic strategies for prion and Alzheimer's diseases 135
Decoding the function of the N-terminal tail of the cellular prion protein to inspire novel therapeutic avenues for neurodegenerative diseases 134
Ok google, how could i design therapeutics against prion diseases? 134
An N-terminal polybasic domain and cell surface localization are required for mutant prion protein toxicity 131
Analysis of the cerebellar proteome in a transgenic mouse model of inherited prion disease reveals preclinical alteration of calcineurin activity 130
A mutant prion protein sensitizes neurons to glutamate-induced excitotoxicity 126
The N-terminal, polybasic region of PrP C dictates the efficiency of prion propagation by binding to PrP Sc 125
Enantiomers of the prion protein degrader SM875: Production and configurational assignment, in silico analysis and in vitro evaluation 122
The hydrophobic core region governs mutant prion protein aggregation and intracellular retention 122
The cellular prion protein beyond prion diseases 122
The Anti-Prion Antibody 15B3 Detects Toxic Amyloid-β Oligomers 121
Modeling PrPSc Generation Through Deformed Templating 120
Aggregated, wild-type prion protein causes neurological dysfunction and synaptic abnormalities 116
The toxicity of a mutant prion protein is cell-autonomous, and can be suppressed by wild-type prion protein on adjacent cells 112
The N-terminal, polybasic region is critical for prion protein neuroprotective activity 111
Defective cyclophilin A induces TDP-43 proteinopathy: implications for amyotrophic lateral sclerosis and frontotemporal dementia 111
Astrocytic microdomains from mouse cortex gain molecular control over long-term information storage and memory retention 110
A designer chaperone against prion diseases 109
Prion protein ligands as therapeutic agents for neurodegenerative disorders 105
Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein 102
Proteasome inhibition and aggregation in Parkinson's disease: A comparative study in untransfected and transfected cells 100
The Compelling Demand for an Effective PrPC-Directed Therapy against Prion Diseases 100
Generation, optimization and characterization of novel anti-prion compounds 99
Epitope scanning indicates structural differences in brain-derived monomeric and aggregated mutant prion proteins related to genetic prion diseases 98
Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation 95
Immunopurification of pathological prion protein aggregates 93
Structural Basis of Mutation-Dependent p53 Tetramerization Deficiency 91
Non-infectious aggregates of the prion protein react with several PrP Sc-directed antibodies 89
GFP-tagged mutant prion protein forms intra-axonal aggregates in transgenic mice 88
Human prion proteins with pathogenic mutations share common conformational changes resulting in enhanced binding to glycosaminoglycans 88
null 86
Pliability in the m6A-Binding Region Extends Druggability of YTH Domains 85
Proteomic analysis of spinal cord of presymptomatic amyotrophic lateral sclerosis G93A SOD1 mouse 82
A Method for Identifying Intermediates 79
Targeting the cellular prion protein to treat neurodegeneration 78
Multiple biochemical similarities between infectious and non-infectious aggregates of a prion protein carrying an octapeptide insertion 77
Identification of the zebrafish homologues of IMPG2, a retinal proteoglycan 76
Role of lipid rafts and GM1 in the segregation and processing of prion protein 76
Doxycycline Inhibition of a Pseudotyped Virus Transduction Does Not Translate to Inhibition of SARS-CoV-2 Infectivity 71
Redox regulation of cyclophilin A by glutathionylation 70
Ion channels induced by the prion protein: Mediators of neurotoxicity 66
Functional, pathogenic, and pharmacological roles of protein folding intermediates 64
Gene expression profiling in trigeminal ganglia from Cntnap2-/- and Shank3b-/- mouse models of autism spectrum disorder 62
Ligands binding to the prion protein induce its proteolytic release with therapeutic potential in neurodegenerative proteinopathies 62
null 62
Infectious and pathogenic forms of PrP 51
Small molecules inducing the degradation of the cellular prion protein 46
Prion protein promotes copper toxicity in Wilson disease 44
A quinolin-8-ol sub-millimolar inhibitor of UGGT, the ER glycoprotein folding quality control checkpoint 40
Small moleules inducing the degradation of the cellular prion protein 38
Doxycycline inhibition of a pseudotyped virus transduction does not translate to inhibition of sars-cov-2 infectivity 33
The evolution of eukaryotic linear motifs governing the function of androgen receptor from fish to Homo sapiens 29
All-Atom Simulation of the HET-s Prion Replication 25
Mapping cryptic phosphorylation sites in the human proteome 23
Ligands binding to the cellular prion protein induce its protective proteolytic release with therapeutic potential in neurodegenerative proteinopathies 16
Beneficial effects of synthetic torpor in a fast-progressing mouse model of amyotrophic lateral sclerosis 16
Therapeutic Trajectories in Human Prion Diseases 11
Prion protein at the crossroads of physiology and disease 9
Totale 8.200
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.182
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 1.059
selected - selezionate 0
volume - volumi 1.208
Totale 40.449
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021548 0 0 0 0 0 108 51 83 50 112 98 46
2021/2022852 52 217 7 33 8 21 35 190 35 63 99 92
2022/2023990 102 129 6 138 108 150 7 69 163 21 49 48
2023/2024417 20 52 23 20 36 86 48 37 4 14 12 65
2024/20251.707 11 15 130 280 121 169 38 80 233 340 145 145
2025/20262.038 269 118 379 629 423 220 0 0 0 0 0 0
Totale 8.200